|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D17.9 |
Benign lipomatous neoplasm, unspecified
|
D179 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 35.80%
|
19.30%
|
12.06%
|
8.76%
|
6.25%
|
4.87%
|
3.50%
|
2.53%
|
1.57%
|
1.27%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D17.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,600
|
1,605
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
898
|
1,028
|
|
J3010
|
FENTANYL CITRATE INJECTION |
575
|
1,080
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
564
|
16,078
|
|
J2405
|
ONDANSETRON HCL INJECTION |
494
|
2,053
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
488
|
489
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
466
|
466
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
455
|
1,763
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
378
|
794
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
335
|
2,409
|
|
G0467
|
FQHC VISIT, ESTAB PT |
303
|
303
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
301
|
301
|
|
80053
|
COMPREHEN METABOLIC PANEL |
279
|
279
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
260
|
1,693
|
|
J7120
|
RINGERS LACTATE INFUSION |
237
|
291
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
227
|
21,473
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
219
|
219
|
|
80048
|
METABOLIC PANEL TOTAL CA |
217
|
217
|
|
76770
|
US EXAM ABDO BACK WALL COMP |
207
|
207
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
196
|
227
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D17.9 related to the following DRG Codes:
606-607
|
